Remicade and Hypercoagulation - a phase IV clinical study of FDA data

Summary:

Hypercoagulation is reported as a side effect among people who take Remicade (infliximab), especially for people who are female, 20-29 old, have been taking the drug for < 1 month also take Methotrexate, and have Asthma.

The phase IV clinical study analyzes which people have Hypercoagulation when taking Remicade. It is created by eHealthMe based on reports of 222,651 people who have side effects when taking Remicade from the FDA, and is updated regularly.

What is Remicade?

Remicade has active ingredients of infliximab. It is often used in crohn's disease. eHealthMe is studying from 224,011 Remicade users. Check the latest studies of Remicade.

What is Hypercoagulation?

Hypercoagulation (increased tendency for clotting of the blood) is found to be associated with 404 drugs and 536 conditions by eHealthMe. Check the latest studies of Hypercoagulation.

On Jan, 15, 2026

222,651 people reported to have side effects when taking Remicade.
Among them, 15 people (0.01%) have Hypercoagulation.

Among these 15 people:

How long have people been on Remicade when they have Hypercoagulation? *

What is the gender of people who have Hypercoagulation when taking Remicade? *

female: 60 %
male: 40 %

What is the age of people who have Hypercoagulation when taking Remicade? *

What are other drugs people take besides Remicade? *

What are other side effects people have besides Hypercoagulation? *

Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 3 people, 20.00%
Gastric Disorder (disease of stomach): 3 people, 20.00%
Pulmonary Embolism (blockage of the main artery of the lung): 3 people, 20.00%
Retinal Vessel Occlusion (a blockage in one of the small arteries): 3 people, 20.00%
Insomnia (sleeplessness): 2 people, 13.33%
Fatigue (feeling of tiredness): 2 people, 13.33%
Ovarian Adenocarcinoma (cancer tumour of ovary): 2 people, 13.33%
Joint Stiffness: 2 people, 13.33%
Sinusitis (inflammation of sinus): 2 people, 13.33%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 13.33%

What are the existing conditions these people have? *

Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands): 1 person, 6.67%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 6.67%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 6.67%
Pain: 1 person, 6.67%
Hypokalemia (low potassium): 1 person, 6.67%
Hypersensitivity: 1 person, 6.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 6.67%
Birth Control: 1 person, 6.67%
Asthma: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Remicade and have Hypercoagulation?

- Check whether Hypercoagulation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Remicade:

Remicade (224,011 reports)

Browse all side effects of Remicade:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypercoagulation:

Hypercoagulation (404 drugs)

Browse all the conditions that are associated with Hypercoagulation:

Hypercoagulation (536 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on infliximab (the active ingredients of Remicade) and Remicade (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.